Joana Scopel

Medical Cannabis In Canada Faces Decline: What's Behind The 38% Drop In Registrations?

Canada’s medical hashish panorama is going through a profound transformation.For the reason that legalization of leisure marijuana in 2018, there was a steep decline in each affected person registrations and spending. The problem now lies in deciphering the explanations...

New York Expands Cannabis Licensing After Legal Delays And Tug Of War Between David And Goliath

New York's hashish panorama is about for a big transformation.Licensing EnlargementThe New York State Workplace of Hashish Administration (OCM) introduced that it'sΒ increasing its licensing program for leisure marijuana, after quite a few delays that introduced all the course of...

Why 280e Change Spells Good News For Cannabis Cash Flow: Jason Wild Weighs In

Jason Wild, govt chairman of TerrAscend Corp TRSSF, spoke on the Benzinga Hashish Capital Convention in Miami. The dialogue primarily revolved across the state of the trade and its future outlook.In case you're fascinated with extra insights from Wild,...

Cannabis Valuation Jumps Post-Rescheduling Recommendation, Viridian Report Reveals

In a probably game-changing determination, the Division of Well being and Human Companies (HHS)Β lately really useful the DEAΒ to contemplate reclassifyingΒ hashish from its Schedule I standing β€” a classification that denotes no medical worth, on par with substances like heroin...

Building A Strong Digital Presence For Cannabis Brands: Expert Tips To Adapt To Every Local Market

"In hashish, the trade is extraordinarily hyperlocal, with every market having its personal set of rules, hashish taxonomy, and product preferences," Randa McMinn, chief advertising and marketing officer of WM Know-how, Inc.Β MAPS, often called Weedmaps, informed Benzinga Hashish in...

Is Federal Legalization of Cannabis a Complex Issue?

According to the founder, president, and CIO of NewLake Capital Partners Inc., Anthony Coniglio, federal legalization is the key catalyst for the cannabis industry's growth. However, he acknowledges that it will take many years to achieve this milestone....

Insights from Curaleaf Chairman on Future Steps in Cannabis Rescheduling by the DEA

The recent recommendation by the Health and Human Services Department (HHS) to the Drug Enforcement Administration (DEA) regarding the rescheduling of cannabis has significant implications for the industry, says Boris Jordan, founder and executive chairman of the board...

The HHS Rescheduling Proposal: Verano CEO Reflects on the Potential Impact on the Cannabis Industry

"This is a momentous occasion," says George Archos, CEO of Verano Holdings Corp (VRNO, VRNOF), in response to the recent recommendation by the Department of Health and Human Services (HHS) for the Drug Enforcement Administration (DEA) to reclassify...

Examining the Discrepancy: Are Cannabis Regulations Hindering the Industry Compared to Beer?

Luke Anderson, one of the co-founders of Cann, introduced a thought-provoking query that resonated throughout the recent Benzinga Cannabis Capital Conference held in Miami. The question was simple yet impactful: "Shouldn't we rethink potency-based regulations?" Anderson highlighted the...

The Potential Impact of HHS Recommendation on Cannabis Brands: Insights from Leading Cannabis Finance Conference

The Implications of Cannabis Rescheduling for Brands The perception of cannabis in the United States is undergoing a significant change. Once considered a Schedule I drug, cannabis might soon be reclassified as a Schedule III substance by the Department of...